Inflammation and Atherosclerosis

As a chronic inflammatory disease of the arterial wall, atherosclerosis is a leading cause of death and morbidity worldwide. This conference will highlight molecular mechanisms giving rise to the disturbed equilibrium of vascular homeostasis, lipid accumulation, immune responses and their clearance during atherogenesis. Leading specialists in the field will present recent observations linking genetic variants, lipids and inflammation, as well as providing insights into the role of inflammatory cell subsets, their mediators and signaling mechanisms in atheroprogression. Novel treatment options to interfere with these mechanisms, including peptide- and microRNA-based therapeutics, will be discussed.

+ show speakers and program
•Christoph Binder (Medical University of Vienna, Austria)

•Myron Cybulsky (University of Toronto, Canada)

•Stefanie Dimmeler (Goethe-University Frankfurt am Main, Germany)

•Ebru Erbay (Bilkent University, Turkey)

•Frederic Geissman (King's College London, UK)

•Beat Imhof (University of Geneva, Switzerland)

•Eicke Latz (University of Bonn, Germany)

•François Mach (University of Geneva, Switzerland)

•Ziad Mallat (University of Cambridge, UK)

•Stephane Potteaux (Inserm, France)

•Daniel Rader (University of Pennsylvania, US)

•Katey Rayner(New York University, US)

•Alan Tall (Columbia University, US)

•Christian Weber (Ludwig Maximilians University Munich, Germany)

20 Sep - 21 Sep 2012
meeting website